Assessing Safety of NIPOX in Peritoneal Carcinomatosis of CRC

NCT03253133 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Oxaliplatin
DRUG: LV5FU or Folfiri
DRUG: Oxycodone

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle